Evotec secures deal worth up to USD 74m for smallpox vaccine development
Evotec has signed an agreement with the US Department of Defense to develop an agent against orthopox viruses, which include smallpox and mpox.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Bavarian Nordic CFO: More monkeypox orders may follow
For subscribers
EU orders 110,000 monkeypox vaccine doses for member states
For subscribers